Join life science experts in this kick-off to ’25 with a live discussion to review evolving healthcare policy and GP regulations and how they will affect you and your company. Expect coverage on:

• Potential Impacts from the New Administration
• Effects from the Inflation Reduction Act and the next list of drugs up for price negotiation
• The CMS Final Rule
• Insights on other Federal and State Drug Pricing and Regulations
• PDABs
• 340B
• And more!

Moderator:

Amanda Tucker
Director, Solutions Delivery
Northridge Insight

Panelists:

Angie Franks
Chief Executive Officer
Kalderos

Sabrina Aery
Executive Director, US Government Programs, US Field Access
Bristol Myers Squibb

Rujul Desai
Partner
Covington & Burling

Chris Weiser
Senior Corporate Counsel, US Market Access Legal
Sanofi